The use of gentamicin in peritoneal dialysis. II. Microbiologic and clinical results.
D058186:Acute Kidney Injury / Q000188:drug therapy; D000421:Alcaligenes / Q000302:isolation & purification; D002177:Candidiasis / Q000209:etiology; D002228:Carbenicillin / Q000627:therapeutic use; D002512:Cephalothin / Q000627:therapeutic use; D004357:Drug Synergism; D004926:Escherichia coli / Q000302:isolation & purification; D005839:Gentamicins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000188:drug therapy; D007962:Leukocytes; D010068:Oxacillin / Q000627:therapeutic use; D010406:Penicillins / Q000627:therapeutic use; D010530:Peritoneal Dialysis; D010538:Peritonitis / Q000188:drug therapy* / Q000382:microbiology; D011552:Pseudomonas Infections / Q000188:drug therapy; D012440:Saccharomyces / Q000302:isolation & purification; D013203:Staphylococcal Infections / Q000188:drug therapy
D005839:Gentamicins; D010406:Penicillins; D002228:Carbenicillin; D002512:Cephalothin; D010068:Oxacillin